We were "there" yesterday where we were a year ago with little apparent progression, no tablets, no trials. All we have done is given Pfizer and others time to work on their treatments. How many are at Stage 2 and 3 development? At the current rate of non development, I fear PAA and MPL will be left at the starting gate with regards to the Covid/SARS/Virus treatments race. There is no way little old PAA can peg back the might of Pfizer and other majors starting from the rear. It needed to be in front, way in front.
AGM Shareholder Questions, page-8
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.005(2.50%) |
Mkt cap ! $99.71M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 20.5¢ | 20.0¢ | $66.86K | 327.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 27750 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 84999 | 3 |
View Market Depth
| Last trade - 14.42pm 27/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |